Consistently, when calculated by the values of AUC using serial dilutions, serum levels of anti-PRMT5 antibodies also demonstrated an increase in patients with SSc relative to HC, SLE or SjS (online supplemental figure S3A). Here, PRMT5 is linked to systemic sclerosis.